abstract |
The application relates to a compound of formula (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, that modulates the activity of BTK. The present invention relates to a pharmaceutical composition comprising a compound of (I) and a method for treating or preventing a disease involving BTK. |